• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Capstone Therapeutics Corp (OP: CAPS )

    3.200 UNCHANGED
    Last Price Updated: 11:47 AM EDT, Oct 16, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 3.200
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 3.200
    Today's Range 3.200 - 3.200
    52wk Range 3.200 - 7.000
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Capstone Holding Corp. Reinstates Tax Benefit Plan
    Via ACCESSWIRE
    Capstone Holding Corp. Announces Change in Board of Directors
    Via ACCESSWIRE

    Performance

    YTD
    -36.00%
    -36.00%
    1 Month
    N/A
    N/A
    3 Month
    -28.89%
    -28.89%
    6 Month
    -36.00%
    -36.00%
    1 Year
    -54.29%
    -54.29%

    More News

    Read More
    Capstone Holding Corp. Announces Change of Equity Ownership in Diamond Products Holding, LLC
    Via ACCESSWIRE
    Capstone Holding Corp. Announces CFO Change
    Via ACCESSWIRE
    Capstone Therapeutics Corp. Announces Results of Annual Meeting
    Via ACCESSWIRE
    Capstone Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder, BP Peptides, LLC
    From Capstone Therapeutics Corp
    Via AccessWire
    Capstone Therapeutics Corp. Announces Results of Annual Meeting
    From Capstone Therapeutics Corp
    Via AccessWire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.